C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
12/2004
12/29/2004	EP1491527A1 Process for preparing acylsulfamoylbenzamides
12/29/2004	EP1491190A1 Decomposition inhibitor for extracellular matrix of cartilage
12/29/2004	EP1491187A1 Preventive or therapeutic agent for kidney disease
12/29/2004	CN1182110C Process for preparation of diphenyl ether compounds
12/29/2004	CN1181825C Use of colchinol derivatives in preparation of vascular damaging agents drug
12/29/2004	CA2529257A1 Methods and compositions for treating amyloid-related diseases
12/29/2004	CA2529256A1 Methods and compositions for treating amyloid-related diseases
12/28/2004	US6835853 Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith
12/28/2004	US6835753 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt
12/28/2004	US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
12/28/2004	US6835749 Sulfohydroxamic acids and sulfohydroxamates and their use as MEK inhibitors
12/28/2004	US6835739 Benzamides and related inhibitors of factor Xa
12/28/2004	US6835495 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
12/23/2004	WO2004110989A1 N-hydroxy-7-(arylamino)heptanamide derivatives useful for treating hyper-proliferative disorders
12/23/2004	WO2004110339A2 Method for selective targeting of apoptotic cells and small molecule ligands used thereof
12/23/2004	US20040260075 an azo compound with a sulfonate, sulfonamide and aminonaphthyl groups; light fastness, heat resistance, insolubility in water, organic solvent
12/23/2004	US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence
12/23/2004	US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents
12/23/2004	CA2529486A1 Method for selective targeting of apoptotic cells and small molecule ligands used thereof
12/22/2004	EP1487785A2 Novel florfenicol-type antibiotics
12/22/2004	EP1487430A1 Methods for treating diseases related to intraocular pressure
12/22/2004	EP1487428A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
12/22/2004	EP1174028B1 Sulfonamide derivatives
12/22/2004	EP1086076B1 Sulfonamide inhibitors of aspartyl protease
12/22/2004	CN1556101A Extraction technology of Hanbaicalein, medicinal composition and preparation technology of medicine
12/16/2004	WO2004108661A1 Amidino compounds as cysteine protease inhibitors
12/16/2004	WO2003063797A8 Cycloalkyl inhibitors of potassium channel function
12/16/2004	US20040254237 Acid amide derivatives, process for producing these, and pest agent containing these
12/16/2004	US20040254103 Water-soluble shps as novel alkylating agents
12/16/2004	CA2526694A1 Amidino compounds as cysteine protease inhibitors
12/15/2004	EP1486495A1 Lipoic acid derivatives and their use in treatment of disease
12/15/2004	EP1486207A2 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
12/15/2004	EP1485387A1 Carbamates as hiv protease inhibitors
12/15/2004	EP1485345A2 Urokinase inhibitors, production and use thereof
12/15/2004	EP1485079A2 Small molecule entry inhibitors
12/15/2004	EP1068180B1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors
12/15/2004	CN1554649A Metabotropic glutamate receptor antagonists for treating central nervous system diseases
12/14/2004	US6831199 Pyrimidine compounds and derivatives thereof
12/14/2004	US6831105 For therapy and prophylaxis of cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/14/2004	US6830760 Glyburide composition
12/09/2004	WO2004106292A1 Haloethyl urea compounds and their use to attenuate, inhibit or prevent non-cancerous pathogenic cellular proliferation and diseases associated therewith
12/09/2004	WO2004106291A1 Haloethyl urea compounds and the use thereof to attenuate, inhibit or prevent cancer cell migration
12/09/2004	WO2004106290A1 Amino alcohol derivatives, phamaceutical compositions containing the same, and use of both
12/09/2004	WO2004106280A1 CaSR ANTAGONIST
12/09/2004	WO2004080389A3 Hydroxyeicosadienamide compounds
12/09/2004	WO2004078144A3 Diphenylethylene compounds and uses thereof
12/09/2004	US20040248983 Potent analgesic and antiinflammatory effects; antiinflammatory agents; treatment of pain and inflammation; N-(3-cyclohexylphenyl)-4-hydroxy-3-methoxyphenylacetamide
12/09/2004	US20040248937 protein tyrosine phosphatase inhibitors such as N-[(4-{[4,6-bis(4-methoxyphenyl)pyrimidin-2-yl]amino}phenyl)sulfonyl]-N-methyl-L-phenylalanine, used for treatment of metabolic disorders related to insulin resistance or hyperglycemia
12/09/2004	US20040248897 Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions
12/09/2004	US20040248882 Noninsulin dependent diabetes, obesity, hypercholesterolemia, inflammatory disorders; reduced side effects; such as 5-(4-acetylbenzenesulfonamido-2-fluorophenoxy)-3-chloropyridine
12/09/2004	US20040248815 Substituted amino acids as erythropoietin mimetics
12/09/2004	CA2568609A1 Haloethyl urea compounds and their use to attenuate, inhibit or prevent non-cancerous pathogenic cellular proliferation and diseases associated therewith
12/09/2004	CA2568607A1 Haloethyl urea compounds and the use thereof to attenuate, inhibit or prevent cancer cell migration
12/08/2004	EP1484313A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
12/08/2004	EP1484301A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
12/08/2004	EP1483276A1 Ferrocenyl ligands and the use thereof in catalysis
12/08/2004	EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
12/08/2004	EP1482924A2 Cathepsin cysteine protease inhibitors
12/08/2004	EP1482919A1 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes
12/08/2004	EP1482896A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482895A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1341754B1 Substituted anthranilic acids
12/08/2004	EP1216227B1 Preparation of sulfonyl imine compounds
12/08/2004	CN1178906C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/08/2004	CN1178898C Method for producing N-(3-amino-4-fluorophenyl)-sulphonamides, N-(3-amino-4-fluorophenyl) carboxyic acid amides and N-(3-amino-4-fluorophenyl) carbamates
12/07/2004	US6828460 Resorcinol derivatives
12/02/2004	WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004	US20040242872 Method of preparing 4-(imidazole-1-yl)benzenesulphonamide derivatives
12/02/2004	US20040242695 N-(2-n-propylpentanoyl)taurin-N',N'-dimethylamide; epilepsy, psychotic and bipolar disorders, chronic pain, headaches, migranes, brain ischemia; high bioavailability; antiepileptic, antiischemic agents
12/02/2004	US20040242684 Method and compositions for inhibiting cell proliferative disorders
12/02/2004	US20040242585 Acylsulfamide inhibitors of factor VIIa
12/02/2004	US20040242456 For controlling weeds, especially in crops of useful plants, or in inhibiting plant growth
12/02/2004	US20040242455 which exerts potent and selective activated blood coagulation factor X inhibitory activity and is useful for prevention or treatment of disease associated therewith
12/01/2004	EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004	EP1480948A1 Semicarbazide derivatives and their use as antithrombotics
12/01/2004	EP1480944A2 Substituted aryl ketones
12/01/2004	EP1480941A2 Urea derivatives as hiv aspartyl protease inhibitors
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	CN1551869A Novel compound
12/01/2004	CN1551866A Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
12/01/2004	CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004	CN1177832C Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
12/01/2004	CN1177829C Substituted sulphonyl cyanamides, method for producing same and their use as medicament
12/01/2004	CN1177785C Method for preparing a non-crystallizable to polyol syrup
11/2004
11/30/2004	US6826033 Beta 3 adrenergic receptor agonists; treatment of pollakiuria, urinary incontinence, obesity or diabetes
11/30/2004	US6825231 Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them
11/30/2004	US6824987 Small molecule printing
11/25/2004	WO2004100950A1 ‘(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)-propyl!phenyl derivatives as beta2 agonists
11/25/2004	WO2004007407A3 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
11/25/2004	US20040236085 Solid-phase nucleophilic fluorination
11/25/2004	US20040235911 hydroxyamidines; antibiotic resistance
11/25/2004	US20040235908 Treating an a-chemokine mediated disease; melanoma, gastric carcinoma, and non-small cell lung cancer, gingivitis, respiratory viruses, herpes viruses, hepatitis viruses, HIV, kaposi's sarcoma associated virus and atherosclerosis
11/25/2004	US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004	US20040235825 Administering compounds such as N-[4-[2-[2-(1-naphthyl)propanoylamino]phenyl]butanoyl]-(3,5-dimethylisoxazol-4-yl)sulfonamide for prophylaxis and therapy of pain, allodynia, hyperalgesia, pruritus, urticaria, atopic dermatitis, contact dermatitis, allergic conjunctivitis, asthma, rhinitis, sneeze
11/25/2004	US20040234622 Sulfonamide derivatives
11/25/2004	DE4307422B4 Verfahren zur Herstellung von Clavulansäuresalzen Process for the preparation of salts of clavulanic acid
11/25/2004	CA2525886A1 N-sulphonylated amino acid derivatives and their use as matriptase inhibitors
11/25/2004	CA2525006A1 `(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)-propyl!phenyl derivatives as beta2 agonists
11/24/2004	EP1479666A1 Ester compound and medicinal use thereof

1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 177